Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Neurol ; 26(7): 979-985, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-30706593

RESUMO

BACKGROUND AND PURPOSE: The prevalence and duration of non-motor symptoms (NMS) in prodromal Parkinson's disease (PD) has not been extensively studied. The aim of this study was to determine the prevalence and duration of prodromal NMS (pNMS) in a cohort of patients with recently diagnosed PD. METHODS: We evaluated the prevalence and duration of pNMS in patients with early PD (n = 154). NMS were screened for using the Non-Motor Symptom Questionnaire (NMSQuest). We subtracted the duration of the presence of each individual NMS reported from the duration of the earliest motor symptom. NMS whose duration preceded the duration of motor symptoms were considered a pNMS. Individual pNMS were then grouped into relevant pNMS clusters based on the NMSQuest domains. Motor subtypes were defined as tremor dominant, postural instability gait difficulty (PIGD) and indeterminate type according to the Movement Disorder Society Unified Parkinson's Disease Rating Scale revision. RESULTS: Prodromal NMS were experienced by 90.3% of patients with PD and the median number experienced was 4 (interquartile range, 2-7). A gender difference existed in the pNMS experienced, with males reporting more sexual dysfunction, forgetfulness and dream re-enactment, whereas females reported more unexplained weight change and anxiety. There was a significant association between any prodromal gastrointestinal symptoms [odds ratio (OR), 2.30; 95% confidence interval (CI), 1.08-4.89, P = 0.03] and urinary symptoms (OR, 2.54; 95% CI, 1.19-5.35, P = 0.016) and the PIGD phenotype. Further analysis revealed that total pNMS were not significantly associated with the PIGD phenotype (OR, 1.10; 95% CI, 0.99-1.21, P = 0.068). CONCLUSIONS: Prodromal NMS are common and a gender difference in pNMS experienced in prodromal PD may exist. The PIGD phenotype had a higher prevalence of prodromal gastrointestinal and urinary tract symptoms.


Assuntos
Ansiedade/epidemiologia , Doença de Parkinson/diagnóstico , Disfunções Sexuais Fisiológicas/epidemiologia , Tremor/diagnóstico , Idoso , Ansiedade/diagnóstico , Ansiedade/fisiopatologia , Feminino , Marcha/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Doença de Parkinson/fisiopatologia , Prevalência , Sintomas Prodrômicos , Disfunções Sexuais Fisiológicas/diagnóstico , Disfunções Sexuais Fisiológicas/fisiopatologia , Inquéritos e Questionários , Tremor/fisiopatologia
2.
J R Coll Physicians Edinb ; 46(3): 160-162, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27959349

RESUMO

Nitrous oxide is commonly used as an analgesic and anaesthetic agent. Nitrous oxide is also in use in industry as an aerosol propellant and is now recognised as a recreational drug whose use is growing, especially among the young. Nitrous oxide from whipped cream canisters is inhaled to produce a dissociative, intoxicated state. Nitrous oxide is known to inactivate vitamin B12 via oxidation, which can precipitate a demyelinating myelopathy akin to the classical B12 deficiency syndrome, subacute combined degeneration of the spinal cord. This case describes a young woman with chronic pain and a poor nutritional state who took regular nitrous oxide as an opiate-sparing agent. She developed a progressive subacute myelopathy with a sensory level, profoundly impaired joint position sense, extensor plantars and required a wheelchair. Once diagnosed, she responded well to a regime of nitrous oxide withdrawal, high-dose B12 replacement and physiotherapy. The case illustrates the need for clinical teams to be able to dentify a nitrous oxide-precipitated myelopathy as its use as a drug of abuse increases; particularly in the case of malnourished patients who receive nitrous oxide surgically or obstetrically.


Assuntos
Acidentes por Quedas , Analgésicos não Narcóticos/efeitos adversos , Dor Crônica/tratamento farmacológico , Doenças Desmielinizantes/induzido quimicamente , Óxido Nitroso/efeitos adversos , Doenças da Medula Espinal/induzido quimicamente , Vitamina B 12/metabolismo , Adulto , Analgésicos não Narcóticos/uso terapêutico , Anestésicos Inalatórios/efeitos adversos , Anestésicos Inalatórios/uso terapêutico , Doenças Desmielinizantes/complicações , Doenças Desmielinizantes/metabolismo , Feminino , Humanos , Óxido Nitroso/uso terapêutico , Manejo da Dor/efeitos adversos , Doenças da Medula Espinal/complicações , Doenças da Medula Espinal/metabolismo , Deficiência de Vitamina B 12
3.
J R Coll Physicians Edinb ; 46(3): 182-186, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27959355

RESUMO

Research can be a difficult area for the novice to break into. A number of different obstacles face the new researcher, starting with selecting a suitable supervisor, writing a workable protocol and obtaining permissions from all the relevant organisations. This beginner's guide walks the fledging researcher through the required steps, including formulating a research question, designing a protocol and completing the Integrated Research Application System form to obtain the required permissions. The aim is to demystify the terms used in research and expose some of the pitfalls the authors experienced so that others can avoid them! Although challenges can arise throughout the research process, we aim to help you get underway.


Assuntos
Projetos de Pesquisa , Pesquisadores , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...